6.12BMarket Cap-12413P/E (TTM)
297.250High280.035Low484.94KVolume281.330Open279.130Pre Close140.60MTurnover3.88%Turnover RatioLossP/E (Static)21.31MShares299.98052wk High7.20P/B3.59BFloat Cap119.76052wk Low--Dividend TTM12.51MShs Float415.800Historical High--Div YieldTTM6.17%Amplitude6.600Historical Low289.938Avg Price1Lot Size
Madrigal Pharmaceuticals Stock Forum
MDGL gained as much as 15.2% to a $294.44 intraday high after Wolfe lauded the company's breakthrough liver drug Rezdiffra, according to published reports.
The U.S. Food and Drug Administration approved Rezdiffra in March as the first treatment fornonalcoholic steatoh...
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings(CERE.US)$
$Amicus Therapeutics(FOLD.US)$
$Iovance Biotherapeutics(IOVA.US)$
$Arcellx(ACLX.US)$
$Nuvalent(NUVL.US)$
$Apogee Therapeutics(APGE.US)$
$Inhibrx(INBX.US)$
$Fusion Pharmaceuticals(FUSN.US)$
$Rhythm Pharmaceuticals(RYTM.US)$
$Vaxcyte(PCVX.US)$
$Soleno Therapeutics(SLNO.US)$
$Medtronic(MDT.US)$
$Madrigal Pharmaceuticals(MDGL.US)$